Stockreport

Werewolf Therapeutics Full Year 2024 Earnings: EPS Misses Expectations [Yahoo! Finance]

Werewolf Therapeutics, Inc.  (HOWL) 
PDF US$1.63 loss per share (further deteriorated from US$1.05 loss in FY 2023). NasdaqGS:HOWL Earnings and Revenue History March 12th 2025 All figures shown in the char [Read more]